Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTRN12616000385448Phase 4Completed
Phase 4, open-label, single-arm trial of bupivacaine in None, sponsored by Mehmet Canturk. Primary endpoint: Effect of hip-to-shoulder size ratio on spread of spinal anesthesia. Started Oct 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ACTRN12616000385448.